Close

Ratings by Guggenheim (Debjit Chattopadhyay)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/18/2024 NewAmsterdam Pharma Co NV NAMS New Coverage Buy
(N/A)
16.75
(22.49)
34.27% Details
12/21/2023 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
12/21/2023 Soleno Therapeutics Inc. SLNO Maintain Buy
(N/A)
 
 
  Details
12/21/2023 Beam Therapeutics Inc BEAM Maintain Buy
(N/A)
 
 
  Details
11/21/2023 Soleno Therapeutics Inc. SLNO New Coverage Buy
(N/A)
27.96
(42.87)
53.33% Details
8/14/2023 Centessa Pharmaceuticals CNTA Maintain Buy
(N/A)
 
 
  Details
7/31/2023 Prime Medicine PRME New Coverage Buy
(N/A)
14.84
(6.81)
-54.11% Details
6/12/2023 Centessa Pharmaceuticals CNTA New Coverage Buy
(N/A)
4.61
(10.99)
138.39% Details
1/26/2023 Dyne Therapeutics DYN New Coverage Buy
(N/A)
13.51
(27.96)
106.96% Details
10/13/2022 Ultragenyx Pharma RARE Upgrade Buy
(Neutral)
38.47
(46.72)
21.45% Details
6/27/2022 Alnylam Pharmaceuticals ALNY Downgrade Neutral
(Buy)
147.50
(153.24)
3.89% Details
5/2/2022 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
4/5/2022 Taysha Gene Therapies TSHA Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Ionis Pharmaceuticals IONS New Coverage Buy
(N/A)
33.38
(44.56)
33.49% Details
3/1/2022 Beam Therapeutics Inc BEAM Maintain Buy
(N/A)
 
 
  Details
2/25/2022 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
2/24/2022 Intellia Therapeutics NTLA Maintain Buy
(N/A)
 
 
  Details
2/3/2022 Alnylam Pharmaceuticals ALNY Upgrade Buy
(Neutral)
145.26
(153.24)
5.49% Details
1/5/2022 Beam Therapeutics Inc BEAM New Coverage Buy
(N/A)
78.31
(33.96)
-56.63% Details
12/16/2021 Taysha Gene Therapies TSHA New Coverage Buy
(N/A)
14.24
(3.19)
-77.6% Details
12/1/2021 Vertex VRTX Maintain Buy
(N/A)
 
 
  Details
10/5/2021 Intellia Therapeutics NTLA New Coverage
(N/A)
126.78
(26.90)
-78.78% Details
7/15/2021 Ultragenyx Pharma RARE New Coverage Neutral
(N/A)
84.74
(38.47)
-54.6% Details
5/6/2021 Freeline FRLN New Coverage Buy
(N/A)
11.25
(6.48)
-42.4% Details
1/7/2021 Sangamo BioSciences SGMO New Coverage Neutral
(N/A)
16.01
(0.63)
-96.06% Details
1/6/2021 uniQure BV QURE Upgrade Buy
(Neutral)
37.77
(5.34)
-85.86% Details